Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 292 of 1,261
  1. US 11207423

    Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs

    Northwestern University · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  2. US 11207395

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  3. US 11207356

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  4. US 11207351

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  5. US 11207342

    High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  6. US 11207333

    Compositions comprising triterpenoids and uses thereof for treating optic neuropathy

    REGENERA PHARMA LTD. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  7. US 11207323

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  8. US 11207327

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  9. US 11207328

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  10. US 11207314

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  11. US 11207299

    Biphenyl sulfonamide compounds for the treatment of type IV collagen diseases

    Travere Therapeutics, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  12. US 11207211

    Lacrimal drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  13. US 11206824

    Gas delivery device comprising a gas releasing molecule and a gas permeable membrane

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  14. AR 119500

    DERIVADOS DE 1,2,4-OXADIAZOL-5-ONA PARA EL TRATAMIENTO DEL CÁNCER

    BASILEA PHARM INT AG [CH] · Granted Dec 22, 2021 · Expires Dec 17, 2041

    granted
  15. US 11202831

    Solid solution compositions and use in cardiovascular disease

    Infirst Healthcare Limited · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  16. US 11202804

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  17. US 11202819

    Use of C-type natriuretic peptide variants to treat osteoarthritis

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  18. US 11203600

    Kinase inhibitors and uses thereof

    DENALI THERAPEUTICS INC. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  19. US 11202784

    Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

    Corcept Therapeutics Incorporated · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  20. US 11202787

    Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  21. US 11206005

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    CG Discovery, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  22. US 11203749

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  23. US 11203602

    Thioester prodrugs of macrocycles as inhibitors of histone deacetylases

    OnKure, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  24. US 11203618

    Campylobacter immunogenic compositions and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.